False synergy between vancomycin and β-lactams against glycopeptide-intermediate Staphylococcus aureus (GISA) caused by inappropriate testing methods-Reference-Cited by-同舟云学术

False synergy between vancomycin and β-lactams against glycopeptide-intermediate Staphylococcus aureus (GISA) caused by inappropriate testing methods

Published:2004-04 Issue:4 Volume:10 Page:342-345
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Goldstein F.W.,Atoui R.,Ben Ali A.,Nguyen J.C.,Ly A.,Kitzis M.D.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference11 articles.

1. Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus;Mainardi;J Infect Dis,1995

2. Quincampoix JC, Carbonne A, Loyer D et al. Follow-up of a nosocomial outbreak of methicillin-resistant strains of Staphylococcus aureus (MRSA) with decreased susceptibility to teicoplanin (DST) [abstract C167]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial agents and Chemotherapy. Toronto, Canada, Washington DC. American Society for Microbiology 1997.

3. Vancomycin-resistant Staphylococcus aureus: a new-model of antibiotic resistance;Hiramatsu;Lancet Inf Dis,2001

4. Vancomycin-resistant Staphylococcus aureus-Pennsylvania 2002;Anonymous;Morb Mortal Wkly Rep,2002

5. Vancomycin resistant S. aureus: no apocalypse now;Goldstein;Clin Microbiol Infect,2003

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vitro Activity of Peptide Antibiotics in Combination With Other Antimicrobials on Extensively Drug-Resistant Acinetobacter baumannii in the Planktonic and Biofilm Cell;Frontiers in Pharmacology;2022-05-11

2. The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus;Microbiology Spectrum;2021-10-31

3. Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model;Antibiotics;2020-10-14

4. Updates on Combination Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia;Current Infectious Disease Reports;2020-09-09

5. Combination Therapy With Vancomycin and Ceftaroline for Refractory Methicillin-resistant Staphylococcus aureus Bacteremia: A Case Series;Clinical Therapeutics;2017-01